Evidence map›Paper›PMID 31357730›Full record

ArticleInternational journal of molecular sciences2019

Fluorescence Enhancement Effect of TiO

Koki Kanehira, Yukiko Yano, Hisashi Hasumi, Hideo Fukuhara, Keiji Inoue, Kazuhiro Hanazaki, Masahiro Yao

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Advanced Nanostructured Coatings Based on Doped TiOMolecules (Basel, Switzerland) · 2023
    Review
  2. Nanoparticle-Based Techniques for Bladder Cancer Imaging: A Review.International journal of molecular sciences · 2023
    Review
  3. Review
  4. Article
  5. The Effects of TiOInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Koki KanehiraBiotechnology Group, TOTO Ltd. Research Institute, Chigasaki 253-8577, Japan. koki.kanehira@jp.toto.com.
Yukiko YanoBiotechnology Group, TOTO Ltd. Research Institute, Chigasaki 253-8577, Japan.
Hisashi HasumiDepartment of Urology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
Hideo FukuharaCenter for Photodynamic Medicine, Kochi Medical School, Kohasu, Oko, Nankoku, Kochi 783-8505, Japan.
Keiji InoueCenter for Photodynamic Medicine, Kochi Medical School, Kohasu, Oko, Nankoku, Kochi 783-8505, Japan.
Kazuhiro HanazakiCenter for Photodynamic Medicine, Kochi Medical School, Kohasu, Oko, Nankoku, Kochi 783-8505, Japan.
Masahiro YaoDepartment of Urology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
Kōchi University · JPYokohama City University · JPToto (Japan) · JP

Funding

Japan Society for the Promotion of Science JP17K16805
6 · The paper itself

Abstract

Photodynamic diagnosis (PDD) can improve diagnostic accuracy by using PDD agents such as 5-aminolevulinic acid (ALA). However, the weakness and photobleaching of fluorescence of PDD agents may lead to insufficient fluorescence visibility for the detection of cancer during resection operations. We focused on the "fluorescence enhancement effect" resulting from the addition of polyethylene glycol-modified titanium dioxide nanoparticles (TiO

Indexed as

Aminolevulinic AcidCell Line, TumorFluorescenceHumansNanoparticlesNeoplasmsPolyethylene GlycolsTitaniumUrinary Bladder NeoplasmsAminolevulinic AcidPolyethylene GlycolsTitaniumtitanium dioxidecellular uptakefluorescence enhancement effectphotodynamic diagnosispolyethylene glycol-modified titanium dioxide nanoparticles

Identifiers

PMID31357730
PMCPMC6695909
OpenAlexW2966352014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.